SUMMARY
Ketorolac trometamol is an injectable nonsteroidal anti-inflammatory drug (NSAID) useful for the control of postoperative pain. We noted several regimens in use by our colleagues to achieve the aim of opiatesparing analgesia, and noted that some previous studies in laparoscopic gynaecological surgery have shown benefit from NSAID administration [1] [2] [3] [4] . However other papers show no benefit [5] [6] [7] [8] . This topic was the subject of an extensive review by Souter et al 9 . We noted a reluctance in this day procedure facility to administer either NSAID at a significant interval preoperatively, which would be desirable given the known pharmacokinetic properties of the drugs [10] [11] [12] . Although more expensive, the parenteral preparation may be more acceptable and convenient in this regard. The type of laparoscopic surgery may also determine the severity of the postoperative pain. However, in practice both drugs are administered at induction prior to minor laparoscopic procedures.
The purpose of this double-blind, placebocontrolled and prospective trial was to compare the analgesic effect of a single intramuscular dose of ketorolac with that of a single rectally administered dose of indomethacin and placebo, all administered at induction to day patients undergoing minor laparoscopic surgery.
Published reports of renal failure 13, 14 and the implication of laparoscopy as a specific risk factor 15 in the development of this side-effect led us to abandon the trial. None the less, we feel the results had sufficient significance to warrant a communication.
METHODS
Following approval for the study from the Ethics and Research Committee, written informed consent was obtained from women, aged 18 to 55 years and weighing 40 to 90 kg, attending for elective minor laparoscopic procedures (including diagnostic laparoscopy and minor procedural laparoscopy such as diathermy of endometriosis and cyst aspiration but excluding laparoscopic sterilization) as day patients at the free-standing day procedure unit. We excluded women already taking or sensitive to NSAIDs or aspirin, those with asthma, hepatic or renal disease and those with peptic ulcer disease or a bleeding disorder or those on anticoagulants.
Subjects were allocated by simple randomization to three groups. The intended sample size was 150 patients. All received both a rectal suppository and IM injection at the time of induction, as follows:
Group I-indomethacin 100 mg PR (Indocid, Merck Sharp and Dohme) and saline 1 ml IMI.
Group K-ketorolac 30 mg IMI (Toradol ® , Syntex) and placebo rectal suppository (Novata-B base, manufactured by the hospital pharmacist). Group P-placebo saline 1 ml IMI and placebo rectal suppository.
The administration of both drugs was under the control of a nurse (TL), who did not divulge the active agent to treating doctors or nurses.
All patients received a similar anaesthetic induction with fentanyl 1.5 µg/kg IV, droperidol 1 mg IV and propofol 2 to 2.5 mg/kg. Muscle relaxation was achieved with vecuronium, atracurium or alcuronium for intubation and anaesthesia was maintained with nitrous oxide, oxygen and enflurane, with neostigmine 2.5 mg and atropine 1.2 mg given for reversal. A standard postoperative analgesia and anti-emetic regimen was available for all patients; fentanyl 10 µg bolus IV five-minutely prn repeated up to five times, metoclopramide 10 mg IV prn and/or two tablets each containing paracetamol 500 mg and codeine 8 mg (Panadeine ® , Winthrop) were given when required at the discretion of the recovery room nursing staff and on patient request and recorded for comparison.
The quality of analgesia was assessed in two ways after arrival in recovery: 1. At 30 minutes, 60 minutes and 180 minutes (or on discharge from the facility, where this occurred sooner) on a 100 mm linear analog pain scale. 2. By recording the requirement for postoperative analgesia.
Time to awakening was measured from arrival in recovery by the nursing staff in continuous attendance. In addition specific enquiry was made about shoulder or chest pain, muscle pain, pain at injection site, sore throat, headache, nausea, bruising or bleeding at the operative site or any other complaint during the recovery period.
Demographic data (including age, weight, duration of procedure and time to first verbal response) and fentanyl usage were compared with ANOVA. Visual analog pain scores were compared with Kruskal-Wallis one-way analysis of variance on ranks. Group differences were determined "post hoc" using the all-pair-wise multiple comparison procedure (Dunn's method). The other noncontinuous variables were compared by Chi-square analysis. A probability of type 1 error of less than 5% was considered significant.
RESULTS
No patient suffered any complication from drugs administered according to the trial protocol; however, one patient was inadvertently given a second dose of ketorolac while in the recovery room and so was dropped from subsequent observation. Table 1 shows the demographic data. All groups are similar with respect to age, weight, height and duration of operation and time to awakening. There was a trend towards less fentanyl use during recovery in both treatment groups compared with the placebo group, but this was not significant (P=0.1). The frequency of requests for oral analgesics followed a similar pattern.
There was no significant difference in pain scores between the groups at 30 and 60 minutes. However, a significant difference was noted at the final assessments, with those given ketorolac having a lower pain score.
No intergroup differences were noticeable on direct questioning during the recovery period. There was no difference in the frequency of complaints of pain at injection site, sore throat, headache or nausea. Inspection by recovery staff showed the same incidence of bleeding from wounds or bruising in each group. No patient required overnight admission or prolonged stay in the day procedure centre.
DISCUSSION
Prostaglandins play a significant role in the mediation of post-surgical pain and their inhibition by NSAIDs suggests an attractive supplement to opiate analgesia in this situation 16 . However, while their efficacy in a variety of surgical procedures has been demonstrated [17] [18] [19] , as discussed above no clear benefit is seen with all laparoscopic procedures, some authors finding them an effective analgesic 1-4 while others found no benefit [5] [6] [7] [8] . In this group with generally very low pain scores, differences may be hard to distinguish.
Certainly it has been suggested that earlier administration of the NSAIDs may improve analgesia in the postoperative period 20 . In several of the successful studies referred to above the NSAIDs were administered as premedication or at least one hour prior to completion of surgery. Our results would tend to support this practice. Alternatively the studies should be extended to assess other analgesic requirement and quality of analgesia after discharge 21 . It could also be useful to compare the time to discharge between the groups. A comparison with a simple analgesic such as paracetamol would also be interesting. If immediate postoperative analgesia is the desired goal, administration of intramuscular ketorolac or rectal indomethacin at induction is of questionable value.
Questions about the role of NSAIDs in the development of acute postoperative renal failure are of particular concern. Its occurrence after single doses of ketorolac and the possible contribution of the raised intraabdominal pressure produced by the pneumoperitoneum during laparoscopic surgery led us to abandon the trial as these case reports came to hand [13] [14] [15] . The small gains demonstrated may not justify the risk of such a serious side-effect. While it is the fate of newer drugs to attract such interest the other NSAIDs have similar effects on renal function 22, 23 . Whether reducing the dose of the NSAIDs 24 would reduce this risk is not known. Similarly the role of the magnitude and duration of raised intraabdominal pressure and the patient's hydration requires further study. We conclude that ketorolac administered at induction provides significant analgesia evident in the later recovery period following minor laparoscopic surgery.
